Globe Life executive share sale draws attention, shares trade near 52-week high
22.06.2026 - 18:05:31 | ad-hoc-news.de
By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-22, 17:59.
Globe Life (US37959E1029) is back in focus on the NYSE after a fresh insider transaction. Executive vice president Rebecca E. Zorn reported the sale of 2,000 shares this week in a filing with the U.S. Securities and Exchange Commission, as summarized by Investing.com.
What the SEC filing shows
According to the recent Form 4 disclosure, Zorn, who serves as executive vice president and chief talent officer at Globe Life, sold 2,000 shares of company stock on June 18, 2026. The reported sale proceeds totaled approximately 340,193 U.S. dollars, based on a volume-weighted average price of 170.0967 dollars per share.
The shares in the transaction were sold at prices ranging from 169.70 to 170.41 dollars, which places the trades near Globe Life’s 52-week high of 172.74 dollars on the NYSE. Before executing the sale, Zorn had acquired an equal number of 2,000 shares through the exercise of employee stock options, so the filing records both the option exercise and the subsequent sale.
Analyst targets and recent earnings
Alongside the insider activity, analyst houses continue to update their models for the S&P 500 insurer. Truist Securities recently raised its price target for Globe Life shares to 185 dollars from 180 dollars, citing an increase in its 2026 earnings per share estimate to 15.60 dollars from 15.30 dollars. Raymond James lifted its price target more aggressively to 208 dollars from 188 dollars and maintained a Strong Buy rating, pointing to the company’s solid cash flow generation.
BMO Capital Markets also adjusted its view, moving its price target to 150 dollars from 148 dollars while reiterating a Market Perform stance and highlighting about a 4 percent increase in the midpoint of Globe Life’s excess cash flow guidance. Zacks Investment Research currently assigns the shares a Rank #2 (Buy) with a Momentum Score of B, reflecting the stock’s recent performance profile.
All news and analysis on the Globe Life shares
Key figures, filings and analyst commentary on the Globe Life equity are available in the dedicated stock overview.
How Globe Life earns its money
Globe Life generates most of its revenue from life and supplemental health insurance policies sold to lower middle- and middle-income households in the United States. The group operates through subsidiaries such as American Income Life, Liberty National Life, and United American, combining direct response and agent-based distribution models.
Where the shares trade today
The Globe Life shares (US37959E1029) trade on the NYSE under the ticker GL; around mid-day U.S. trading, recent indications place the price near 175 dollars per share. That level leaves the stock close to its 52-week high of roughly 172.74 dollars and reflects a roughly 43 percent gain over the past 12 months.
Key data on the Globe Life shares
- Company: Globe Life Inc.
- ISIN: US37959E1029
- WKN: 859099
- Ticker: GL
- Trading venue: NYSE
- Price (as of 2026-06-22, 15:43): 174.74 USD
- Market cap: 15.9 billion USD (as of 2026-06-22)
- Sector / industry: Financials / Life & Health Insurance
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All data are based on publicly available sources and may be subject to change.
